Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINUS: Ultrasound-monitored Meniscal Wall Betamethasone Infiltration on Pain
NCT06527235Phase 3Recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Mar 2025
- Primary completion
- Jun 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Betamethasone Infiltration with Placebo Infiltration (2 arms). Primary endpoint: Meniscal Pain at 1 month. Started Mar 2025; status: recruiting.
02
Drugs
betamethasone
Beyond the preview
Go deeper on NCT06527235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06527235.